ReShape Lifesciences Submits FDA PMA Supplement Application For The Next-Generation Lap-Band 2.0
Portfolio Pulse from Happy Mohamed
ReShape Lifesciences has submitted a Premarket Approval (PMA) supplement application to the FDA for its next-generation Lap-Band 2.0, featuring enhanced band reservoir technology. The company expects feedback from the FDA by year-end.
June 26, 2023 | 8:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
ReShape Lifesciences submitted a PMA supplement application to the FDA for its Lap-Band 2.0, which could lead to broad adoption if approved.
ReShape Lifesciences' submission of the PMA supplement application for Lap-Band 2.0 is a significant milestone for the company. If approved, the product could see broad adoption by existing Lap-Band surgeons and new adopters, potentially boosting the company's revenues and stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100